908 Devices Inc (MASS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, 908 Devices Inc (MASS) has a cash flow conversion efficiency ratio of 0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.32 Million) by net assets ($143.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
908 Devices Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how 908 Devices Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does 908 Devices Inc carry for a breakdown of total debt and financial obligations.
908 Devices Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 908 Devices Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alvopetro Energy
V:ALV
|
0.126x |
|
Bicycle Therapeutics plc
F:50BA
|
-0.032x |
|
Ingram Micro Bilisim Sistemleri A.S.
IS:INGRM
|
0.002x |
|
Starz Entertainment LLC
NASDAQ:STRZ
|
-0.033x |
|
Salmon Evolution Holding AS
OL:SALME
|
-0.040x |
|
Sonmez Filament Sentetik Iplik ve Elyaf Sanayi AS
IS:SONME
|
0.017x |
|
Dynamix Corporation Unit
NASDAQ:DYNXU
|
-0.005x |
|
Artius II Acquisition Inc. Class A Ordinary Shares
NASDAQ:AACB
|
-0.001x |
Annual Cash Flow Conversion Efficiency for 908 Devices Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of 908 Devices Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see 908 Devices Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $143.70 Million | $-23.69 Million | -0.165x | +37.55% |
| 2024-12-31 | $114.59 Million | $-30.25 Million | -0.264x | -74.32% |
| 2023-12-31 | $165.49 Million | $-25.06 Million | -0.151x | -37.89% |
| 2022-12-31 | $190.60 Million | $-20.93 Million | -0.110x | +18.97% |
| 2021-12-31 | $214.60 Million | $-29.08 Million | -0.136x | -556.11% |
| 2020-12-31 | $139.04 Million | $4.13 Million | 0.030x | -82.94% |
| 2019-12-31 | $-63.17 Million | $-11.00 Million | 0.174x | -1.77% |
| 2018-12-31 | $-50.18 Million | $-8.90 Million | 0.177x | -- |
About 908 Devices Inc
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of… Read more